Claudio Fiocchi, MD; James K. Roche, MD, PhD; William M. Michener, MD
Study Objective: To assess whether healthy members of families of patients with inflammatory bowel disease share an immune reactivity to gut epithelial cell antigens.
Design: Assessment of immune reactivity against epitheli-al-cell-associated components (ECAC).
Methods: Detection of specific anti-ECAC serum antibodies by antibody-dependent cellular cytotoxicity (percent specific lysis) and by immunoblotting (Western blots).
Patients: Index cases (131) and first-degree relatives in 17 families with 2 or more affected members, and 13 with only 1 member affected.
Main Results: Compared with a gastrointestinal disease control group (0.5% ± 0.8%), specific lysis against ECAC-C (colon-derived) among patients with inflammatory bowel disease was significantly greater in both multiply affected (8.4% ± 8.2%; P <0.01) and singly affected (5.2% ± 5.4%; P < 0.05) families. In contrast, specific lysis by patients with other inflammatory processes of the small and large bowel (1.1% ± 1.4%) or autoimmune disease (0.7% ± 1.0%) did not differ from that of the gastrointestinal disease control group. Among relatives of patients with inflammatory bowel disease (index cases), specific lysis was also significantly higher than in the control group (4.8% ± 5.5% for multiply affected, P < 0.01, and 4.3% ± 5.5% for singly affected, P < 0.05). Relatives of patients with chronic inflammatory liver disease had a level of lysis (0.6% ± 0.9%) similar to that of controls. The prevalence of antibodies to ECAC-C was 69.7% among patients with chronic inflammatory bowel disease, and 55.7% among relatives; both prevalences were significantly higher than that of the control group (8.0%, P < 0.001). Using small-bowel-derived ECAC, the prevalence of antibodies among patients with inflammatory bowel disease and relatives tives was also significantly higher than that of controls. Reactivity of sera was directed to a 160- and a 137-kilodalton macromolecule.
Conclusions: Immune sensitization to intestinal epithelial antigens is common in families with chronic inflammatory bowel disease; its high frequency among asymptomatic relatives suggests it may represent a primary phenomenon, perhaps predisposing individuals to gut tissue injury.
Fiocchi C, Roche JK, Michener WM. High Prevalence of Antibodies to Intestinal Epithelial Antigens in Patients with Inflammatory Bowel Disease and Their Relatives. Ann Intern Med. 1989;110:786–794. doi: 10.7326/0003-4819-110-10-786
Download citation file:
Published: Ann Intern Med. 1989;110(10):786-794.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use